Department of Neurology, F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; MD-PhD Program of Harvard & MIT, Harvard Medical School, Boston, MA 02115, USA.
Department of Neurology, F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Brain Behav Immun. 2024 Jul;119:317-332. doi: 10.1016/j.bbi.2024.03.041. Epub 2024 Mar 27.
Complement proteins facilitate synaptic elimination during neurodevelopmental pruning, but neural complement regulation is not well understood. CUB and Sushi Multiple Domains 1 (CSMD1) can regulate complement activity in vitro, is expressed in the brain, and is associated with increased schizophrenia risk. Beyond this, little is known about CSMD1 including whether it regulates complement activity in the brain or otherwise plays a role in neurodevelopment. We used biochemical, immunohistochemical, and proteomic techniques to examine the regional, cellular, and subcellular distribution as well as protein interactions of CSMD1 in the brain. To evaluate whether CSMD1 is involved in complement-mediated synapse elimination, we examined Csmd1-knockout mice and CSMD1-knockout human stem cell-derived neurons. We interrogated synapse and circuit development of the mouse visual thalamus, a process that involves complement pathway activity. We also quantified complement deposition on synapses in mouse visual thalamus and on cultured human neurons. Finally, we assessed uptake of synaptosomes by cultured microglia. We found that CSMD1 is present at synapses and interacts with complement proteins in the brain. Mice lacking Csmd1 displayed increased levels of complement component C3, an increased colocalization of C3 with presynaptic terminals, fewer retinogeniculate synapses, and aberrant segregation of eye-specific retinal inputs to the visual thalamus during the critical period of complement-dependent refinement of this circuit. Loss of CSMD1 in vivo enhanced synaptosome engulfment by microglia in vitro, and this effect was dependent on activity of the microglial complement receptor, CR3. Finally, human stem cell-derived neurons lacking CSMD1 were more vulnerable to complement deposition. These data suggest that CSMD1 can function as a regulator of complement-mediated synapse elimination in the brain during development.
补体蛋白在神经发育性修剪过程中促进突触消除,但神经补体调节机制尚不清楚。CUB 和 Sushi 多结构域 1(CSMD1)可在体外调节补体活性,在大脑中表达,并与精神分裂症风险增加相关。除此之外,人们对 CSMD1 的了解甚少,包括它是否在大脑中调节补体活性,或者是否在神经发育中发挥作用。我们使用生化、免疫组织化学和蛋白质组学技术来研究大脑中 CSMD1 的区域、细胞和亚细胞分布以及蛋白质相互作用。为了评估 CSMD1 是否参与补体介导的突触消除,我们检查了 Csmd1 敲除小鼠和 CSMD1 敲除人类干细胞衍生神经元。我们研究了老鼠视觉丘脑的突触和回路发育,这个过程涉及补体途径活性。我们还量化了老鼠视觉丘脑突触和培养的人类神经元上补体沉积。最后,我们评估了培养的小胶质细胞对突触体的摄取。我们发现 CSMD1 存在于突触中,并与大脑中的补体蛋白相互作用。缺乏 Csmd1 的小鼠显示出补体成分 C3 水平升高,C3 与突触前末端的共定位增加,少突胶质细胞生成的视网膜-丘脑束突触减少,以及在这个回路中补体依赖性细化的关键时期,视网膜输入的眼特异性分离异常。体内缺失 CSMD1 增强了体外小胶质细胞对突触体的吞噬作用,而这种作用依赖于小胶质细胞补体受体 CR3 的活性。最后,缺乏 CSMD1 的人类干细胞衍生神经元更容易受到补体沉积的影响。这些数据表明,CSMD1 可作为发育过程中大脑中补体介导的突触消除的调节剂。